These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 7692641)

  • 1. Responsiveness of preactivated B cells to IL-2 and IL-6. Effect of cyclosporine and rapamycin.
    Hornung N; Raskova J; Raska K; Degiannis D
    Transplantation; 1993 Oct; 56(4):985-90. PubMed ID: 7692641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cyclosporine and rapamycin on immunoglobulin production by preactivated human B cells.
    Kim HS; Raskova J; Degiannis D; Raska K
    Clin Exp Immunol; 1994 Jun; 96(3):508-12. PubMed ID: 8004821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory influence of IL-4 on human B cell responsiveness.
    Jelinek DF; Lipsky PE
    J Immunol; 1988 Jul; 141(1):164-73. PubMed ID: 2837507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin 4 inhibits the proliferation but not the differentiation of activated human B cells in response to interleukin 2.
    Defrance T; Vanbervliet B; Aubry JP; Banchereau J
    J Exp Med; 1988 Oct; 168(4):1321-37. PubMed ID: 3262709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant IL 2 but not recombinant interferon-gamma stimulates both proliferation and IgM secretion in a Ly-1+ clone of neoplastic murine B cells (BCL1).
    Brooks KH; Vitetta ES
    J Immunol; 1986 Nov; 137(10):3205-10. PubMed ID: 2945863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cyclosporine and Sirolimus on interleukin-15-driven proliferation of OKT3-preactivated human lymphocytes.
    Degiannis D; Kalteziotis V; Thalassinos A; Kapsalis A; Kroupis C; Koniavitou K
    Transplant Proc; 1998 Jun; 30(4):948-9. PubMed ID: 9636382
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of HLA class I and class II antigens in activation and differentiation of B cells.
    Giudizi MG; Biagiotti R; Almerigogna F; Alessi A; Tiri A; Del Prete GF; Ferrone S; Romagnani S
    Cell Immunol; 1987 Aug; 108(1):97-108. PubMed ID: 3111726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation by cyclosporine (CsA) of the in vitro release of soluble CD23 (sCD23) and of the in vitro production of IL-6 and IgM.
    Hornung N; Degiannis D
    Scand J Immunol; 1993 Sep; 38(3):287-92. PubMed ID: 8356404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-2 dependence of the promotion of human B cell differentiation by IL-6 (BSF-2).
    Splawski JB; McAnally LM; Lipsky PE
    J Immunol; 1990 Jan; 144(2):562-9. PubMed ID: 2295801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 15-Deoxyspergualin inhibits interleukin 6 production in in vitro stimulated human lymphocytes.
    Borg AJ; Kumagai-Braesch M; Möller E
    Transpl Immunol; 1996 Jun; 4(2):133-43. PubMed ID: 8843590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of human B cell proliferation and differentiation by tumor necrosis factor-alpha and interleukin 1.
    Jelinek DF; Lipsky PE
    J Immunol; 1987 Nov; 139(9):2970-6. PubMed ID: 3117883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of interleukin 2 in the regulation of proliferation and IgM synthesis of human newborn mononuclear cells.
    Punnonen J
    Clin Exp Immunol; 1989 Mar; 75(3):421-6. PubMed ID: 2784745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of IL-5 expression by IL-2 is resistant to the immunosuppressive agents cyclosporin A and rapamycin.
    Valentine JE; Sewell WA
    Int Immunol; 1997 Jul; 9(7):975-82. PubMed ID: 9237106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-2 responsiveness of lectin-induced lymphoblasts: soluble IL-2 receptor release and differential in vitro effects of immunosuppressants.
    Hornung N; Raskova J; Raska K; Degiannis D
    Int J Immunopharmacol; 1992 Jul; 14(5):753-60. PubMed ID: 1512072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct inhibition of human CD8+ lymphocyte activation by cyclosporine A and Rapamune-Sirolimus.
    Combates NJ; Degiannis D; Raskova J; Raska K
    Clin Immunol Immunopathol; 1995 Dec; 77(3):221-8. PubMed ID: 7586731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of CTL induction by rapamycin: IL-2 rescues granzyme B and perforin expression but only partially restores cytotoxic activity.
    Makrigiannis AP; Hoskin DW
    J Immunol; 1997 Nov; 159(10):4700-7. PubMed ID: 9366393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of dexamethasone, cyclosporine, and rapamycin on T-lymphocyte proliferation in vitro: comparison of cells from patients with glucocorticoid-sensitive and glucocorticoid-resistant chronic asthma.
    Haczku A; Alexander A; Brown P; Assoufi B; Li B; Kay AB; Corrigan C
    J Allergy Clin Immunol; 1994 Feb; 93(2):510-9. PubMed ID: 8120277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the B-cell growth-promoting activity of human IL-4, the co-stimulatory assay with anti-immunoglobulin antibodies. Comparison with the B-cell growth-promoting activity of other lymphokines.
    Almerigogna F; Giudizi MG; Biagiotti R; Alessi A; Defrance T; Banchereau J; Ricci M; Romagnani S
    Immunology; 1989 Jun; 67(2):244-50. PubMed ID: 2502497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro transformation by Epstein-Barr virus induces a switch in growth factor and anti-IgM responsiveness in a human leukemic B cell clone.
    Janssen O; Gillis S; Kabelitz D
    Eur J Immunol; 1990 Jan; 20(1):7-14. PubMed ID: 2155117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of CD5 on B and T cells is suppressed by cyclosporin A, FK-520 and rapamycin.
    Teutsch M; Higer M; Wang D; Wortis HW
    Int Immunol; 1995 Mar; 7(3):381-92. PubMed ID: 7540861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.